Study of influential factor to responsiveness of Tolvaptan in patients with volume overload heart failure -Multicenter prospective observational study
Phase 4
Recruiting
- Conditions
- congestive heart failure
- Registration Number
- JPRN-UMIN000007551
- Lead Sponsor
- Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with hypernatremia 2.Inability of the patient to sense or appropriately respond to thirst 3.Anuric patients 4.Pregnant, possibly pregnant, or nursing women 5.Patients with a history of hypersensitivity to ingredients of Tolvaptan tablets 6.Patients who are otherwise judged inappropriate for inclusion in the study by the investigators
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of body weight
- Secondary Outcome Measures
Name Time Method 1.Change of congestive state 2.Change of urine volume, osmolarity 3.Change of plasma BNP level 4.One-Year Outcomes